/CCRN

Cross Country Healthcare Inc

CCRN

$13.25USD↑+0.08%+0.01 today

MARKET CAP

428.1M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$13 – $13

52W RANGE

$7

$15

AI Summary

Stalk

StalkMedium

The stock is in a Stage 2 advancing phase under a strong parabola-driven rally, consolidating tightly above the rising 9/20 EMAs and the 200 DMA after a steep advance. However, overextension above EMAs and an elevated RSI warn against chasing current highs. Without a Lockout Rally override and given the pattern's vulnerability to abrupt reversal, execution should be deferred until shallow pullbacks into the rising EMAs offer a better entry opportunity.

↑IntelliFi platform has 5,500 users across 500 sites, boosting efficiency
↑Travel demand rose 20% since Q2 start, broad across specialties
↓Q3 revenue fell to $315M, down 7% QoQ and 29% YoY from travel drop

Full analysis →

Buying

4

institutions

Selling

6

institutions

New Positions

3

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	2.75 M	36.33 M	+243.06 K	+54.2%	0.00%
MM Millennium Management LLC Q2 2026	BUYNEW	912.38 K	12.05 M	+912.38 K	+0.0%	0.00%
PA Polar Asset Management Partners Inc. Q2 2026	BUYNEW	272.50 K	3.60 M	+272.50 K	+0.0%	0.08%
RT Renaissance Technologies LLC Q2 2026	SELL	152.68 K	2.02 M	+-92.72 K	-12.6%	0.00%
CA Citadel Advisors LLC Q2 2026	SELL	57.64 K	761.45 K	+-303.82 K	-77.6%	0.00%
JC Jpmorgan Chase & Co Q2 2026	SELL	42.07 K	555.75 K	+-74.60 K	-49.7%	0.00%
MG Man Group Plc Q2 2026	BUYNEW	28.31 K	374.01 K	+28.31 K	+0.0%	0.00%
AC Aqr Capital Management LLC Q2 2026	SELL	21.26 K	280.86 K	+-24.82 K	-35.2%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	SELL	0.00	0.00	+-55.72 K	-100.0%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	SELL	0.00	0.00	+-38.13 K	-100.0%	0.00%